华邦健康预计2025年净利6.6亿元至7.3亿元，同比扭亏为盈

Core Viewpoint - Huabang Health (002004) is expected to achieve a net profit attributable to shareholders of 660 million to 730 million yuan in 2025, a significant turnaround from a loss of 299 million yuan in the same period last year [2] Group 1: Financial Performance - The company anticipates a net profit of 660 million to 730 million yuan for 2025, compared to a loss of 299 million yuan in the previous year, indicating a strong recovery [2] - The expected profit represents a substantial year-on-year improvement, marking a shift from loss to profit [2] Group 2: Business Segments - The agricultural chemical new materials sector has shown signs of partial recovery, contributing positively to the company's performance [2] - The company has actively expanded its market presence and enhanced refined management practices, leading to cost reduction and efficiency improvements [2] - The pharmaceutical and tourism sectors have also experienced steady growth, further supporting the overall performance of the company [2]